Literature DB >> 18579354

Effect of dolomite oral exposure in Wistar rats during organogenesis period of pregnancy.

Alicia Lagarto1, Addis Bellma, Juana Tillán, Tatiana Gabilondo, Isbel Guerra, Zuleira Ocanto, Micaela Couret, Ricardo González.   

Abstract

The potential of oral exposure to dolomite, a natural product that contains calcium and magnesium, to initiate teratogenesis was analyzed in Wistar rats. Animals received dolomite oral dosages of 500 and 1500mg/kg during the period of gestation from day 6-15 post conceptionem (p.c.). Maternal, embryo and fetal toxicity were evaluated. Dolomite exposure did not produce maternal toxicity assessed by clinical observations, body weight gain, hematology parameters and relative organs weight. Signs of embryo-fetal toxicity were not observed. Skeletal malformations and visceral variations were similar in control and dolomite-treated groups. On the other hand, slight increase was observed in fetal body weight in the dolomite-treated group. Treatment with dolomite resulted in significantly decreased incidences of unossified xiphisternum, incomplete ossification of xiphisternum and sternebrae. These effects could be caused by a beneficial influence of calcium and magnesium salts present in dolomite on ossification process. In conclusion, in this study we found that the oral exposure to rats of up to 1500mg/kg of dolomite during organogenesis did not induce significant maternal and embryo-fetal toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579354     DOI: 10.1016/j.etp.2008.05.001

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  2 in total

1.  Characterization of crystalline structures in Opuntia ficus-indica.

Authors:  Margarita Contreras-Padilla; Eric M Rivera-Muñoz; Elsa Gutiérrez-Cortez; Alicia Real del López; Mario Enrique Rodríguez-García
Journal:  J Biol Phys       Date:  2014-12-03       Impact factor: 1.365

2.  Respiratory disorders associated with heavy inhalation exposure to dolomite dust.

Authors:  M Neghab; R Abedini; A Soltanzadeh; A Iloon Kashkooli; S M A Ghayoomi
Journal:  Iran Red Crescent Med J       Date:  2012-09-30       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.